What makes one jar of peanut butter different from another, anyway? Is it worth splurging on brand-name products, or are ...
At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...
The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called aromatic L-amino acid decarboxylase (AADC) deficiency.
What do you think of when you hear the term ‘patent medicine’? Nostrums, snake oil, or quack medicine, probably. These days, ...
A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...